|
|
|
Insider
Information: |
Gagnon Robert E. |
Relationship: |
Director |
City: |
Weston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
359,945 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,893,416 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
359,945 |
|
|
Total
Value |
$3,893,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
12
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
234.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
Premium* |
|
Clean Harbors Inc |
CLH |
EVP CFO and Treasurer |
2012-09-11 |
7,386 |
2012-09-11 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Chief Financial Officer |
2018-08-29 |
321,169 |
2014-06-16 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2024-03-19 |
27,391 |
2018-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-12-01 |
4 |
D |
$116.48 |
$43,214 |
D/D |
(371) |
5,845 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-12-06 |
4 |
AS |
$112.31 |
$89,286 |
D/D |
(795) |
5,050 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-14 |
4 |
AS |
$118.61 |
$66,422 |
D/D |
(560) |
5,050 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-23 |
4 |
D |
$116.70 |
$45,280 |
D/D |
(388) |
5,885 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,223 |
6,273 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-24 |
4 |
OE |
$49.65 |
$52,331 |
D/D |
1,054 |
6,939 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-24 |
4 |
AS |
$115.53 |
$121,769 |
D/D |
(1,054) |
5,885 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-24 |
4 |
D |
$116.39 |
$38,874 |
D/D |
(334) |
5,551 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-28 |
4 |
AS |
$115.03 |
$96,050 |
D/D |
(835) |
4,716 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Vice President, Finance |
|
2012-02-29 |
4 |
AS |
$115.51 |
$82,821 |
D/D |
(717) |
3,999 |
0 |
- |
|
CLH |
Clean Harbors Inc |
EVP CFO and Treasurer |
|
2012-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,386 |
7,386 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2014-06-16 |
4 |
B |
$3.86 |
$19,275 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2014-06-30 |
4 |
A |
$3.87 |
$6,730 |
D/D |
1,739 |
6,739 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2014-12-31 |
4 |
A |
$4.00 |
$7,460 |
D/D |
1,865 |
8,604 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
35,104 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
28,117 |
63,221 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-11-09 |
4 |
B |
$3.08 |
$9,240 |
D/D |
3,000 |
66,221 |
2.74 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-11-12 |
4 |
B |
$2.93 |
$4,395 |
D/D |
1,500 |
67,721 |
2.66 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-01-01 |
4 |
D |
$3.47 |
$8,592 |
D/D |
(2,476) |
65,245 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
177,304 |
242,549 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-11-02 |
4 |
B |
$2.33 |
$11,650 |
D/D |
5,000 |
247,549 |
2.74 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-11-03 |
4 |
B |
$2.34 |
$46,800 |
D/D |
20,000 |
267,549 |
2.74 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2017-01-01 |
4 |
D |
$3.05 |
$33,147 |
D/D |
(10,868) |
256,681 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
217,392 |
474,073 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2017-05-26 |
4 |
B |
$2.33 |
$2,330 |
D/D |
1,000 |
475,073 |
2.66 |
- |
|
100 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|